December 2021

Panacea Biotec is a leading research based Health Management Company, with an annual turnover of approx. Rs. 830 Crores. We are engaged in research, development, manufacture & marketing of Vaccines, Bio-Pharmaceuticals and Pharmaceuticals (Rx & OTC) of international quality and Health Services. All Panacea Biotec plants are accredited by international agencies and they follow current Good Manufacturing Practices, as per WHO guidelines.

Syngene International, an integrated research, development and manufacturing services company, today announced the extension of its long-standing multi-discipline research collaboration with Amgen Inc, one of the world’s leading biotechnology companies. The contract is currently extended until the end of 2026 and its scope includes integrated drug discovery and development solutions in discovery chemistry and biology, peptide chemistry, antibody and protein reagents, pharmacokinetics and drug metabolism, and pharmaceutical development.

Vifor Pharma Group announced the divestment of its finished drug product manufacturing business to CordenPharma, a full-service Contract Development & Manufacturing Organization (CDMO) of APIs, Excipients, Drug Products, and associated Packaging services. This decision reinforces Vifor Pharma’s strategy to transform the company into a multi-brand commercial organization, focusing on its core capabilities in-licensing, partnering and commercializing products in nephrology, and to further grow and maximize opportunities of its iron portfolio.

Basilea Pharmaceutica Ltd a commercial-stage biopharmaceutical company committed to meeting the needs of patients with cancer and infectious diseases, announced that the U.S. Food and Drug Administration (FDA) has approved the company’s Investigational New Drug (IND) application for the novel kinase inhibitor BAL0891, a potential first-in-class mitotic checkpoint inhibitor (MCI) that drives aberrant tumor cell division leading to tumor cell death.

CSIR-Indian Institute of Toxicology Research, (IITR) Lucknow, a constituent laboratory of Council of Scientific & Industrial Research, was established in 1965. This multidisciplinary research institute with the motto ‘Safety to Environment and Health and Service to Industry’ addresses problems critical to human health and environment. CSIR-IITR undertakes research in niche areas of toxicology. These include the impact of industrial and environmental chemicals on human health and ecosystem, and environmental monitoring of pollutants in air, water and soil.

Guru Angad Dev Veterinary and Animal Sciences University was established at Ludhiana by an act of the Punjab Legislature No. 16 of 2005 notified in the Punjab Government Gazette on August 9, 2005 and it started functioning w.e.f. April 21, 2006 for promoting livestock production, health and prevention of the disease(s) through integrated teaching, research and extension programme(s).

National Institute of Pharmaceutical Education and Research (NIPER) is the first national level institute in pharmaceutical sciences with a proclaimed objective of becoming a centre of excellence for advanced studies and research in pharmaceutical sciences. The Government of India has declared NIPER as an 'Institute of National Importance'. It is an autonomous body set up under the aegis of Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India.

The department of Pharmaceutical Sciences, Rungta College of Pharmaceutical Sciences and Research (RCPSR), Bhilai, (affiliated to Chhattisgarh Swami Vivekananda Technical University, Bhilai) Chhattisgarh has been a relent less and pioneer in spreading the Pharmaceutical education in each nook and corner of globe. It has established in 2006 and completing 11 years of successful journey in 2015. The Institute is running Diploma, Graduation, Post-Graduation and PhD. Programs in Pharmacy.

Granules India is a vertically integrated pharmaceutical company, headquartered in Hyderabad, India. We manufacture Active Pharmaceutical Ingredients APIs, Pharmaceutical Formulation Intermediates PFIs and Finished Dosages FDs, distributed to quality conscious customers in both regulated and semi-regulated markets.

Post : Analyst - Regulatory affairs